UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola involved – known as Bundibugyo – kills around a third of those infected and has no proven vaccine yet.
“It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty,” a spokesman added, saying it would depend on animal trials as to whether it could be considered “a promising candidate research vaccine” for Bundibugyo.
